Tag: adverse effects

Neurology

FDA Approves Cannabidiol for Tuberous Sclerosis Complex

Newsemia
The US Food and Drug Administration has expanded its approval for cannabidiol (Epidiolex) oral solution to also treat seizures in tuberous sclerosis complex for patients...
Latest News

Which HCPs Are Most Likely to Get COVID Vaccine?

Newsemia
Medscape’s reader poll also found that few respondents think there will be a readily available vaccine by the end of 2020, but most think one...
Neurology

Hydroxychloroquine Has No Benefit, 'Only Risks' in COVID-19

Newsemia
Hydroxychloroquine has been touted as a potential treatment for COVID-19, but new observational data show it is not only without benefit but it increases death...
Latest News

No Hydroxychloroquine Benefit in Randomized COVID-19 Trial

Newsemia
The 150-patient trial has problems of confounding, according to two experts, and is unable to answer definitively whether hydroxychloroquine can benefit COVID-19 patients or harm...
Latest News

Hydroxychloroquine: Possible COVID Drug Can Be Toxic to Retinas

Newsemia
Before it was a potential COVID-19 therapy, it was a well-studied treatment with an established risk for retinal toxicity. Source link...
Neurology

Best Treatment for Post-Stroke Depression Still Unclear

Newsemia
Choosing the best treatment option for post-stroke depression is still more art than science, with little evidence to support one approach over another, a new...
Neurology

Levetiracetam Oral Solution Recalled in US

Newsemia
Lannett Company has recalled two lots of the anticonvulsant because of microbial contamination, which was identified during an evaluation of a raw material used to...
Neurology

FDA Approves First Vaccine for Dengue, With Restrictions

Newsemia
Dengvaxia is for the prevention of dengue disease caused by all dengue virus serotypes in people aged 9 to 16 years who have previously had...
Neurology

Steer Clear of Driving While Taking Prescribed Opioids?

Newsemia
Higher-dose opioids impair driving performance to a minor degree, but patients still need to be advised of this risk so they can decide whether to...
Neurology

Opioids for Chronic Pain Only Nominally Better Than Placebo

Newsemia
Opioids offer marginal pain-control benefits over placebo for patients with chronic pain and "should not be first-line therapy" for pain management, investigators of a new...
Neurology

Anti-CGRP Monoclonal Antibodies for Migraine Prevention

Newsemia
Dr Deborah Friedman reviews the new anti-CGRP monoclonal antibodies for migraine prevention. American Headache Society and Medscape Source link...
Neurology

Just One Energy Drink Reduces Endothelial Function

Newsemia
A new study shows that consuming just one can of an energy drink was linked to an almost 50% reduction in arterial dilation, which could...
Neurology

Repeated CBD Doses Required for Effective Pain Relief

Newsemia
Repeated administration of cannabidiol (CBD) is needed to treat neuropathic pain and related anxiety, according to new research that shows how the drug acts on...
Neurology

Additional Benefit From Lowering Already Low LDL

Newsemia
Pushing LDL cholesterol below current targets further reduces risk for major cardiovascular events without serious adverse effects, a new meta-analysis finds. Medscape Medical News Source...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World